OBIO's own Klaus Fiebig, VP Strategic Programs, shares his impressions and advice garnered from RESI on MaRS last week highlighting some of the trends and sentiments about early stage fundraising.

This is a two part series so be sure to open up your OBIO Member Update next week!

This weeks blog focuses on the Tales from the Road session with OBIO CAAP company Stephane Langevin, CCO, Pathcore, Michael Tippie, CEO, Lipidomics, Christopher Kent, President & CEO, ODS Medical and Tyler Wanke, CEO, Innoblative.

Click HERE to read the blog